HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

AR231630

a selective 5-HT2C receptor agonist

Also Known As:

AR630

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - AR231630: 1

Experts

1.	Bagnol, Didier: 1 article (01/2018)
2.	Duranton, Flore: 1 article (01/2018)
3.	Faton, Sina: 1 article (01/2018)
4.	Lajoix, Anne-Dominique: 1 article (01/2018)
5.	Tassin, Jean-Pol: 1 article (01/2018)

Related Diseases

1.

AIDS-Related Complex (ARC)

01/01/2018 - "Unexpectedly, intra-ARC injection of AR231630 did not reduce food intake even at the dose of 10 μg, whereas intra-VTA injection of the same dose of AR231630 did. "
01/01/2018 - "AR231630 injected into the VTA, but not into the ARC, dose-dependently reduced locomotor activity elicited by amphetamine. "
01/01/2018 - "Localized microinjections into the VTA or the ARC were used to assess the effects of a highly selective 5-HT2C receptor agonist, AR231630, on the locomotor stimulant effect of amphetamine as well as on food intake. "

Related Drugs and Biologics

1.	5-HT2C Serotonin Receptor
2.	Amphetamine (Amfetamine)